View in EDS HTML Full Text PDF Full Text

Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancer.

Saved in:

Bibliographic Details
Title:	Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancer.
Authors:	Agostini, Antonio^1,2 (AUTHOR), Guerriero, Ilaria³ (AUTHOR), Piro, Geny^1,2 (AUTHOR) geny.piro@policlinicogemelli.it, Quero, Giuseppe⁴ (AUTHOR), Roberto, Luca³ (AUTHOR), Esposito, Annachiara^1,2 (AUTHOR), Caggiano, Alessia^1,2 (AUTHOR), Priori, Lorenzo^1,2 (AUTHOR), Scaglione, Giulia⁵ (AUTHOR), De Sanctis, Francesco⁶ (AUTHOR), Sistigu, Antonella⁷ (AUTHOR), Musella, Martina⁷ (AUTHOR), Larghi, Alberto^8,9 (AUTHOR), Rizzatti, Gianenrico^8,9 (AUTHOR), Lucchetti, Donatella^10,11 (AUTHOR), Alfieri, Sergio⁴ (AUTHOR), Sgambato, Alessandro^10,11 (AUTHOR), Bria, Emilio^1,2 (AUTHOR), Bizzozero, Laura^12,13 (AUTHOR), Arena, Sabrina^12,13 (AUTHOR)
Source:	Journal of Translational Medicine. 11/23/2023, Vol. 21 Issue 1, p1-15. 15p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Description
ISSN:	14795876
DOI:	10.1186/s12967-023-04733-z